Quality of Life and Psychosocial Factors in Renal Transplant Recipients
Overview
Affiliations
An ideal method for quality of life (QOL) assessment in renal transplant recipients (RTR) has not yet been determined. Present assessments of QOL in RTR are lengthy, cumbersome to administer, and difficult to interpret. We used a previously validated single question QOL scale score (QLS) that directly asks about the patients' overall assessment of their QOL; "Considering all parts of my life-physical, emotional, social, spiritual, and financial--over the past 2 days the quality of my life has been ... ". The QLS ranges from 0 ("very bad") to 10 ("excellent"). Patients were contacted prior to their routine office visit when they were free of acute medical problems. Fifty RTR participated. Psychosocial and medical variables included the Beck Depression Inventory, Illness Effects Questionnaire, Multidimensional Scale of Perceived Social Support, time since transplant, age, creatinine, hemoglobin, and albumin levels. Of the patients, 64% were African-American and 48% were women; 94% of patients had a score>5. Mean QLS was 7.5+/-2.3. Perception of a better QOL correlated with less perception of depression and illness effects and with perception of greater social support and satisfaction with life (all P<.05). Perception of QOL did not correlate with age, time since transplantation, creatinine, hemoglobin or albumin levels. We concluded that QLS is a quick tool to measure subjective QOL in RTR for correlation with psychosocial factors of interest in this group. These studies should be replicated in larger multiethnic populations.
Prevalence, risk factors, and severity of erectile dysfunction following renal transplantation.
Miron A, Nistor I, Morosanu C, Siriteanu L, Pricop C, Puia D Int Urol Nephrol. 2024; 57(4):1151-1173.
PMID: 39623195 PMC: 11903514. DOI: 10.1007/s11255-024-04299-9.
Kim J, Wray J, Ridout D, Plumb L, Nitsch D, Robb M BMJ Open. 2024; 14(5):e078150.
PMID: 38806415 PMC: 11138291. DOI: 10.1136/bmjopen-2023-078150.
Harding C, Ephraim P, Davenport C, McElroy L, Mohottige D, DePasquale N Transplant Proc. 2023; 55(10):2403-2409.
PMID: 37945446 PMC: 10872540. DOI: 10.1016/j.transproceed.2023.10.001.
Psychosocial determinants of healthcare use costs in kidney transplant recipients.
Zerbinati L, Guerzoni F, Napoli N, Preti A, Esposito P, Caruso R Front Public Health. 2023; 11:1158387.
PMID: 37333548 PMC: 10272730. DOI: 10.3389/fpubh.2023.1158387.
Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients.
Battaglia Y, Zerbinati L, Piazza G, Martino E, Provenzano M, Esposito P J Clin Med. 2020; 9(4).
PMID: 32252326 PMC: 7230823. DOI: 10.3390/jcm9040995.